These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
178 related items for PubMed ID: 16172185
41. In vivo metabolism and final disposition of a novel nonsteroidal androgen in rats and dogs. Perera MA, Yin D, Wu D, Chan KK, Miller DD, Dalton J. Drug Metab Dispos; 2006 Oct; 34(10):1713-21. PubMed ID: 16815963 [Abstract] [Full Text] [Related]
42. [Pharmacokinetics and metabolism of gallopamil]. Eichelbaum M. Z Kardiol; 1989 Oct; 78 Suppl 5():20-4. PubMed ID: 2631477 [Abstract] [Full Text] [Related]
43. Bioavailability of two oral-tablet and two oral-suspension formulations of naproxen sodium/paracetamol (acetaminophen): single-dose, randomized, open-label, two-period crossover comparisons in healthy Mexican adult subjects. Palma-Aguirre JA, Villalpando-Hernández J, Novoa-Heckel G, Oliva I, Cariño L, López-Bojórquez E, Burke-Fraga V, Namur S, González-de la Parra M. Clin Ther; 2009 Feb; 31(2):399-410. PubMed ID: 19302912 [Abstract] [Full Text] [Related]
44. Bioavailability of two oral formulations of loratadine 20 mg with concomitant ketoconazole: an open-label, randomized, two-period crossover comparison in healthy Mexican adult volunteers. Piñeyro-López A, Pineyro-Garza E, Torres-Alanís O, Reyes-Araiza R, Gómez Silva M, Wacksman N, Lujàn Rangel R, de Lago A, Trejo D, Gonzàlez-de la Parra M, Namur S. Clin Ther; 2006 Jan; 28(1):110-5. PubMed ID: 16490584 [Abstract] [Full Text] [Related]
45. Evaluation of microdosing to assess pharmacokinetic linearity in rats using liquid chromatography-tandem mass spectrometry. Balani SK, Nagaraja NV, Qian MG, Costa AO, Daniels JS, Yang H, Shimoga PR, Wu JT, Gan LS, Lee FW, Miwa GT. Drug Metab Dispos; 2006 Mar; 34(3):384-8. PubMed ID: 16326814 [Abstract] [Full Text] [Related]
46. Dependence of nelfinavir brain uptake on dose and tissue concentrations of the selective P-glycoprotein inhibitor zosuquidar in rats. Anderson BD, May MJ, Jordan S, Song L, Roberts MJ, Leggas M. Drug Metab Dispos; 2006 Apr; 34(4):653-9. PubMed ID: 16434546 [Abstract] [Full Text] [Related]
47. Single-dose safety and pharmacokinetics of brecanavir, a novel human immunodeficiency virus protease inhibitor. Ford SL, Reddy YS, Anderson MT, Murray SC, Fernandez P, Stein DS, Johnson MA. Antimicrob Agents Chemother; 2006 Jun; 50(6):2201-6. PubMed ID: 16723584 [Abstract] [Full Text] [Related]
48. Pharmacokinetics and absolute bioavailability of selegiline following treatment of healthy subjects with the selegiline transdermal system (6 mg/24 h): a comparison with oral selegiline capsules. Azzaro AJ, Ziemniak J, Kemper E, Campbell BJ, VanDenBerg C. J Clin Pharmacol; 2007 Oct; 47(10):1256-67. PubMed ID: 17715422 [Abstract] [Full Text] [Related]
49. A positron emission tomography microdosing study with a potential antiamyloid drug in healthy volunteers and patients with Alzheimer's disease. Bauer M, Langer O, Dal-Bianco P, Karch R, Brunner M, Abrahim A, Lanzenberger R, Hofmann A, Joukhadar C, Carminati P, Ghirardi O, Piovesan P, Forloni G, Corrado ME, Lods N, Dudczak R, Auff E, Kletter K, Müller M. Clin Pharmacol Ther; 2006 Sep; 80(3):216-27. PubMed ID: 16952488 [Abstract] [Full Text] [Related]
50. Changes in pharmacokinetics of anti-HIV protease inhibitors during pregnancy: the role of CYP3A and P-glycoprotein. Mathias AA, Maggio-Price L, Lai Y, Gupta A, Unadkat JD. J Pharmacol Exp Ther; 2006 Mar; 316(3):1202-9. PubMed ID: 16293714 [Abstract] [Full Text] [Related]
51. Saquinavir, nelfinavir and M8 pharmacokinetics following combined saquinavir, ritonavir and nelfinavir administration. Stocker H, Herzmann C, Breske A, Kruse G, Berger M, Schulbin H, Hill A, Steinmüller J, Becker M, Arastéh K, Kurowski M. J Antimicrob Chemother; 2007 Mar; 59(3):560-4. PubMed ID: 17255144 [Abstract] [Full Text] [Related]
52. Dose-dependent pharmacokinetics of a new Na+/H+ exchanger inhibitor KR-33028 in rats. Kim YH, Yoo SD, Kim YS, Lee KH, Lee HS. Biopharm Drug Dispos; 2007 Nov; 28(8):423-9. PubMed ID: 17828714 [Abstract] [Full Text] [Related]
53. Bioavailability of two oral formulations of a single dose of levofloxacin 500 mg: an open-label, randomized, two-period crossover comparison in healthy Mexican volunteers. Galan-Herrera JF, Poo JL, Rosales-Sanchez O, Fuentes-Fuentes E, Cariño L, Burke-Fraga V, Namur S, Parra MG. Clin Ther; 2009 Aug; 31(8):1796-803. PubMed ID: 19808138 [Abstract] [Full Text] [Related]
54. Absence of food effect on the extent of alprazolam absorption from an orally disintegrating tablet. Erdman K, Stypinski D, Combs M, Witt P, Stiles M, Pollock S. Pharmacotherapy; 2007 Aug; 27(8):1120-4. PubMed ID: 17655512 [Abstract] [Full Text] [Related]
55. Pharmacokinetics of L-FMAUS, a new antiviral agent, after intravenous and oral administration to rats: contribution of gastrointestinal first-pass effect to low bioavailability. Chung HJ, Lee JH, Woo SJ, Park HK, Koo CH, Lee MG. Biopharm Drug Dispos; 2007 May; 28(4):187-97. PubMed ID: 17377948 [Abstract] [Full Text] [Related]
56. Simultaneous determination of HIV protease inhibitors amprenavir, atazanavir, indinavir, lopinavir, nelfinavir, ritonavir and saquinavir in human plasma by high-performance liquid chromatography-tandem mass spectrometry. Dickinson L, Robinson L, Tjia J, Khoo S, Back D. J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Dec 27; 829(1-2):82-90. PubMed ID: 16226495 [Abstract] [Full Text] [Related]
57. Microdosing: a valuable tool for accelerating drug development and the role of bioanalytical methods in meeting the challenge. Ings RM. Bioanalysis; 2009 Oct 27; 1(7):1293-305. PubMed ID: 21083052 [Abstract] [Full Text] [Related]
58. Greater immediate gastric acid suppression with lansoprazole 30 mg administered as a 2-minute intravenous bolus injection versus a 30-minute infusion. Metz DC, Devlin JW, Vakily M, Atkinson S, Lloyd E. Pharmacotherapy; 2008 Mar 27; 28(3):301-7. PubMed ID: 18294109 [Abstract] [Full Text] [Related]
59. Bone appetite--using food to boost your Viracept. Clay PG. Posit Aware; 2003 Mar 27; 14(4):29. PubMed ID: 12951947 [No Abstract] [Full Text] [Related]
60. Methadone metabolism and clearance are induced by nelfinavir despite inhibition of cytochrome P4503A (CYP3A) activity. Kharasch ED, Walker A, Whittington D, Hoffer C, Bedynek PS. Drug Alcohol Depend; 2009 May 01; 101(3):158-68. PubMed ID: 19232844 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]